The majority of these pathways are vital for cancer progression, including “Endometrial cancer”, “Renal cell carcinoma”, “ErbB signaling pathway”, “Colorectal cancer”, “Thyroid cancer”, “Thyroid cancer” (Fig. 2E). Here, EGFR is linked to hereditary clear cell renal cell carcinoma.